IP Library › Assignment 024937/0709
Patent Assignment
Reel/Frame 024937/0709

Change of Name

Recorded: 2010-09-03 Pages: 5
Assignor
GENZYME TRANSGENICS CORPORATION
Executed: 2002-05-31
Assignee
GTC BIOTHERAPEUTICS, INC.
175 CROSSING BOULEVARD, SUITE 410, FRAMINGHAM, MASSACHUSETTS, 01702
Covered Property (1)
Transgenically Produced Antithrombin Iii
Patent: 7,928,064 →
Application: 11/284,585 →
Publication: US 2008/0176786
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Dec 22, 2008
From: GTC BIOTHERAPEUTICS, INC.
To: LFB BIOTECHNOLOGIES S.A.S.U.
Reel/Frame 022019/0205 →
Security Agreement Jan 16, 2009
From: GTC BIOTHERAPEUTICS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 022119/0854 →
Assignment of Assignor's Interest Sep 3, 2010
From: DITULLIO, PAUL; MEADE, HARRY; COLE, EDWARD S.
To: GENZYME TRANSGENIC CORPORATION
Reel/Frame 024937/0796 →
Change of Name Jul 18, 2013
From: GTC BIOTHERAPEUTICS, INC.
To: REVO BIOLOGICS, INC.
Reel/Frame 030831/0075 →
Release of Security Interest Mar 11, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 032424/0230 →
Release of Security Interest Mar 14, 2014
From: LFB BIOTECHNOLOGIES S.A.S.U.
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 032448/0045 →